-
US Mortgage Rate Falls for Fourth Week but Remains Above 7%
-
US Jobless Claims Rise to 200,000 but Layoffs Remain Historically Low
-
Italy Raises 2026 Growth View but Warns Energy Will Keep Inflation High
-
Godzilla Minus Zero Review: Takashi Yamazaki’s Anti-Nuclear Allegory
-
Euro-Area Growth Slows to 0.4% While Employment Stalls
-
DA Demands No-Work-No-Pay for Striking Municipal Workers in Coalition Talks
-
UK Economy Grows 0.7% in Third Quarter as Services Lead Expansion
-
US Wholesale Inflation Eases Monthly but Hits a Four-Year Annual High
-
India's Retail Inflation Reaches 6.09% as Food Prices Accelerate
-
India's Wholesale Inflation Jumps to 12.29% as Fuel Costs Surge
-
Malta Emerges as Premier Low-Season Destination for UK Travelers
-
China's October Activity Data Reveal a Weak Start to the Fourth Quarter
-
Japan's Economy Edges Into Contraction as Costly Oil Weighs on Demand
-
Philippines Urges ASEAN and China to Accelerate South China Sea Code of Conduct
-
UK Home Asking Prices Drop £6,745 in November Amid High Mortgage Rates
-
Mbeki Claims No Progress Since 2018; Author Cites Infrastructure and Economic Gains
-
Alex Georgiev Sets Personal Record to Win NCAA Pole Vault at Penn Relays
-
Qatar's Amir and Venezuelan Acting President Discuss Energy Cooperation
-
Emerging Growth Research Highlights Criticality of First Phosphate G7-Backed LFP Battery Onshoring Solution as Cleantech Sector Accelerates Post U.S. Midterms
-
SMX Brings a New Level of Transparency to Gold Trading Through trueGold Technology
-
Westell Technologies, Inc. Announces Its Commencing a Tender Offer
-
Rescue Intellitech Expands Professional Decontamination Portfolio for Fire Departments with DeconWasher(TM) Pro S
-
MicroVision Lidar Powers Commercial Driverless Trucking at Scale with Kodiak AI
-
Expecting a Refund but Owe Back Taxes? Clear Start Tax Explains How the IRS Offset Program Takes It First
-
Cardiff Lexington Announces Third Quarter 2026 Financial Results
-
Ainos Reports Third Quarter 2026 Results and Highlights Expanding AI Nose Commercial Momentum
-
SMX: The Future of Gold Will Be Defined by What We Know About It -Powering Verified Trade and Tokenisation
-
NuRAN Wireless Eliminates Floating-Price Preferred Overhang and Locks In a Fixed C$1.20 Conversion Price
-
GameSquare Holdings Reports 2026 Third Quarter Results with Revenue up 77% YoY and Net Income Reaches $10.1 Million
-
ValorPay UAB Goes Live on T2, the Eurosystem's Real-Time Settlement System
-
CNS Pharmaceuticals Reports Third Quarter 2026 Financial Results and Highlights Progress in Establishing Transformative Therapeutic Pipeline
-
XCF Global Reports Third Quarter 2026 Financial Results & Affirms 2027 Outlook
-
NextSource Materials Appoints Eugene Lee as Chief Financial Officer
-
International Battery Metals Ltd. Reports Second Quarter of Fiscal Year 2027 Financial Results
-
Abasca Resources Engages Northern Arc Public Affairs to Advance Federal Engagement on the Loki Flake Graphite Project
-
AsiaFIN Holdings Corp. Announces Third Quarter 2026 Results, Reporting Strong Nine-Month Financial Performance with Improved Margins
-
Thalia Therapeutics PLC Announces Promising Interim Phase I Data for miRisten in AML
-
Strategic Metals Reports Promising Results From the Rusty and Ranch Projects
-
Golden Minerals Reports Third Quarter 2026 Financial Results
-
OBI Pharma Signs Collaboration and License Agreement with Novartis
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - November 16
-
Blue Chip Capital Group Announces Quotation of its Common Stock on the OTCID and Updates Status of Initial Regulatory Compliance
-
Sharecare Partners With HomeTown Health to Bring AskMD, Funded Through the GREAT Health Program, to More Rural Hospitals and Patients Across Georgia
-
Spartan Capital Adds Institutional Investor, Upsizes Credit Facility to $100 Million
-
Diné Development Corporation Named 2026 Minority-Owned Business of the Year by Dayton Business Journal
-
Orlando Dreamers Announce Hundreds of Millions of Additional Financing Under Initial Letter of Intent
-
How to Remotely Access a PLC? Improve Maintenance Efficiency with InHand 4G/5G Industrial Routers
-
Graid Technology Extends VROC(TM) to AMD EPYC(TM) Platforms, Expanding Choice in Enterprise RAID
-
SMX Targets the Missing Link in Global Gold Markets: Proof
-
Lifeloc Reports Third Quarter 2026 Results
DEA Diversion Officials Scrambling For DOGE Retirement: Corrupt Bureaucrats Blocked Medical Cannabis Research While Patients Suffered
Retirements Reported in DEA's DIVERSION as "DOGE CASUALTIES".
DEA Faces Scrutiny Over Delays in Medical Cannabis Research.
As MMJ BioPharma Cultivation unleashes a legal reckoning, the DEA's unconstitutional Administrative Law system collapses under Supreme Court rulings-forcing Department Of Justice to retreat, leaving DEA officials scrambling for cover. DEA diversion officials will be remembered on its "wall of DISHONOR" for blocking marijuana medicine to suffering patients in need.
WASHINGTON, D.C / ACCESS Newswire / June 29, 2025 / The U.S. Drug Enforcement Administration (DEA) is reeling from a constitutional crisis as its controversial Administrative Law Judge (ALJ) system crumbles under Supreme Court rulings, while MMJ BioPharma Cultivation intensifies its legal battle against the agency's alleged sabotage of medical cannabis research. The fallout has triggered retirements and disciplinary actions within the DEA's Diversion Control Division, with insiders dubbing the removed officials "DOGE Casualties" a nod to their NON alignment with Trump-era policies that prioritized science over obstruction.

The DEA's "Last Stand": An Unconstitutional Tribunal Defies the Supreme Court
For over 2,387 days, MMJ BioPharma Cultivation, a company developing FDA sanctioned cannabis therapies for Huntington's Disease and Multiple Sclerosis, has been trapped in the DEA's Administrative Law hearing process. The exact system the Supreme Court declared unconstitutional in Axon Enterprise v. FTC (2023) and Jarkesy v. SEC (2024). These rulings found such agency tribunals violate:
The Seventh Amendment's right to a jury trial.
The nondelegation doctrine (Congress cannot outsource judicial power to unaccountable ALJs).
Article II's separation of powers (ALJs are insulated from presidential oversight).
In February 2025, the DOJ conceded the system's illegality, refusing to defend it in court. Yet in June, DEA Chief ALJ John Mulrooney II doubled down, denying MMJ's application without a hearing, blocking evidence, and relying on ex parte - communications, a move MMJ CEO Duane Boise called "bureaucratic mutiny".
"The DOJ admits the system is illegal, yet the DEA keeps using it to punish medical research," Boise stated. "This is a shadow court operating in defiance of the Constitution."
The "DOGE Casualties": DEA's Diversion Division Implodes
High-ranking officials linked to the Trump era Department of Government Efficiency (DOGE) initiative are now facing involuntary retirements or disciplinary action, including:
Lead DEA litigator Aarathi Haig (who practices without proper N.J. bar credentials).
The Irony:
MMJ, compliant with FDA orphan drug protocols, was delayed for years while Chinese-linked illicit grow ops flooded the U.S. with pesticide-laced cannabis.
"The DEA had time to sabotage a lawful company but no time to shut down Chinese Communist Party linked farms. That's not negligence; it's systemic failure," Boise said.
DEA Violated Its Own Policy Manual
MMJ's treatment flouted the DEA's own Training and Policy Manual, which mandates:
Timely investigations for applications involving public interest or FDA trials.
Expedited review for orphan drug status and urgent therapeutic need.
No DEA procedural delays as de facto denials, yet MMJ was never granted that DEA treatment.
"The DEA's own manual proves this wasn't just delay; it was sabotage," Boise noted.
The Fallout: Legal, Political, and Human Costs
MMJ's lawsuit could dismantle the DEA's Administrative Law system entirely, while pressure mounts to:
Transfer cannabis oversight to the FDA/NIH (where science, not stigma, governs).
Launch a DOJ probe into Diversion Division misconduct.
Enforce Right-to-Try laws the DEA ignored for terminal patients.
The Human Toll:
Patients with Huntington's and Multiple Sclerosis lost access to potential therapies.
Illicit markets thrived under DEA inaction.
The DEA Road Ahead: A Test for New Leadership
With Terrance Cole nominated as DEA Administrator, advocates demand:
Freeze all ALJ proceedings pending federal court review.
Audit the Diversion Division for bias and corruption.
Prioritize science over outdated cannabis stigma.
"The DEA is a constitutional dead man walking," Boise declared. "Every day it clings to this system, the DEA digs its grave deeper."
A DEA Legacy on the Line
As the MMJ BioPharma Cultivation lawsuit advances, the stakes extend beyond one company. The outcome may determine whether the DEA:
Submits to the rule of law and embraces medical science,
Or collapses beneath the weight of its own unlawful defiance.
Either way, the agency's future and the credibility of American drug policy now hangs in the balance.
As MMJ's case advances, the DEA's legacy may be defined by its defiance of the courts and the patients it failed.
MMJ is represented by attorney Megan Sheehan.
CONTACT:
Madison Hisey
[email protected]
203-231-8583
SOURCE: MMJ International Holdings
View the original press release on ACCESS Newswire
H.Gonzales--AT